[
  {
    "paper_id": "PMID:realistic_001",
    "title": "Phase I trial of immunotherapy in melanoma",
    "type": "clinical_trial",
    "expected_behavior": "Should recognize early-phase limitations"
  },
  {
    "paper_id": "PMID:realistic_002",
    "title": "Systematic review of CD73 inhibitors",
    "type": "review",
    "expected_behavior": "Should not treat as primary evidence"
  },
  {
    "paper_id": "PMID:realistic_003",
    "title": "Mouse model shows CD73 upregulation in tumors",
    "type": "preclinical",
    "expected_behavior": "Should hedge translation to humans"
  },
  {
    "paper_id": "PMID:realistic_004",
    "title": "Correlation between CD73 and survival (n=15)",
    "type": "weak_stats",
    "expected_behavior": "Should note small sample size"
  },
  {
    "paper_id": "PMID:realistic_005",
    "title": "CD73 in breast cancer: conflicting results across studies",
    "type": "contradiction",
    "expected_behavior": "Should present both sides"
  }
]
